Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Molecular Medicine Congress

Evi Lianidou's Biography



Evi Lianidou, Professor, University of Athens

• 1979-1983: BSc Chemistry, , Department of Chemistry, University of Athens, Greece
• 1983-1988: PhD thesis, , Department of Chemistry, University of Athens, Greece.
• 1988-1989: Postdoctoral education: Dr Diamandis’ lab, Department of Clinical Biochemistry and Laboratory Medicine, University of Toronto, Canada
• 1989-up to now: Department of Chemistry, University of Athens, Greece where she is currently Professor of Analytical Chemistry and Clinical Chemistry.
• Elected member of the Committee for Clinical Molecular Biology Curriculum of the International Federation of Clinical Chemistry (IFCC), that offers training in Molecular Diagnostics all over the world by the way of courses and hands on workshop in combination with lectures and methodological issues.
• Head of Analysis of Circulating Tumor Cells (ACTC) lab, Dept of Chemistry, Univ. of Athens.
• Coordinator of the M.Sc. program of Clinical Chemistry, at the Department of Chemistry, University of Athens
• Organizer of the 7th International Symposium on Minimal Residual Disease in Athens, (http://ismrc2009.chem.uoa.gr),
• Organizer of the “Advances in Circulating Tumor Cells: From Basic Research to Clinical Practice” meeting (www.actc2012.org).

Evi Lianidou Image

Molecular Characterization of Circulating Tumor Cells

Tuesday, 3 September 2013 at 11:20

Add to Calendar ▼2013-09-03 11:20:002013-09-03 12:20:00Europe/LondonMolecular Characterization of Circulating Tumor CellsMolecular Medicine Congress in Frankfurt, GermanyFrankfurt, GermanySELECTBIOenquiries@selectbiosciences.com

Circulating Tumor Cell (CTC) analysis is a promising new diagnostic field for cancer patients towards the estimation of risk for metastatic relapse or metastatic progression. Molecular characterization of CTC can provide important information on the molecular and biologic nature of these cells and is very important for the identification of therapeutic targets and resistance mechanisms in CTC, as well as for the stratification of patients and real-time monitoring of systemic therapies.


Add to Calendar ▼2013-09-03 00:00:002013-09-04 00:00:00Europe/LondonMolecular Medicine CongressMolecular Medicine Congress in Frankfurt, GermanyFrankfurt, GermanySELECTBIOenquiries@selectbiosciences.com